These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 22499956

  • 1. Factor VII for excessive bleeding following congenital heart disease surgery.
    Changlani DK, Devendaran V, Murmu UC, Ganesan S, Varghese R, Kumar RS.
    Asian Cardiovasc Thorac Ann; 2012 Apr; 20(2):120-5. PubMed ID: 22499956
    [Abstract] [Full Text] [Related]

  • 2. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ.
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.
    Karsies TJ, Nicol KK, Galantowicz ME, Stephens JA, Kerlin BA.
    Ann Thorac Surg; 2010 Feb; 89(2):570-6. PubMed ID: 20103344
    [Abstract] [Full Text] [Related]

  • 7. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [Abstract] [Full Text] [Related]

  • 8. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery.
    Wittenstein B, Ng C, Ravn H, Goldman A.
    Pediatr Crit Care Med; 2005 Jul; 6(4):473-6. PubMed ID: 15982438
    [Abstract] [Full Text] [Related]

  • 9. Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery.
    Bowman LJ, Uber WE, Stroud MR, Christiansen LR, Lazarchick J, Crumbley AJ, Kratz JM, Toole JM, Crawford FA, Ikonomidis JS.
    Ann Thorac Surg; 2008 May; 85(5):1669-76; discussion 1676-7. PubMed ID: 18442563
    [Abstract] [Full Text] [Related]

  • 10. Recombinant activated factor VII in cardiac surgery: single-center experience.
    Singh SP, Chauhan S, Choudhury M, Malik V, Choudhary SK.
    Asian Cardiovasc Thorac Ann; 2014 Feb; 22(2):148-54. PubMed ID: 24585784
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7).
    Hacquard M, Durand M, Lecompte T, Boini S, Briançon S, Carteaux JP.
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1320-7. PubMed ID: 21550261
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Early experience with activated recombinant factor VII for intractable hemorrhage after cardiovascular surgery.
    Halkos ME, Levy JH, Chen E, Reddy VS, Lattouf OM, Guyton RA, Song HK.
    Ann Thorac Surg; 2005 Apr; 79(4):1303-6. PubMed ID: 15797067
    [Abstract] [Full Text] [Related]

  • 17. A Propensity-Score Matched Analysis on Outcomes Using Recombinant Activated Factor VII in Pediatric Cardiac Surgery.
    Li Y, Zhao W, Luo Q, Wu X, Ding J, Yan F.
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1269-1275. PubMed ID: 30795967
    [Abstract] [Full Text] [Related]

  • 18. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis.
    Karkouti K, Beattie WS, Wijeysundera DN, Yau TM, McCluskey SA, Ghannam M, Sutton D, van Rensburg A, Karski J.
    Transfusion; 2005 Jan; 45(1):26-34. PubMed ID: 15647015
    [Abstract] [Full Text] [Related]

  • 19. Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients.
    Tobias JD, Simsic JM, Weinstein S, Schechter W, Kartha V, Michler R.
    J Intensive Care Med; 2004 Jan; 19(5):270-3. PubMed ID: 15358945
    [Abstract] [Full Text] [Related]

  • 20. Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery?
    Okonta KE, Edwin F, Falase B.
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):690-4. PubMed ID: 22811512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.